|
The products developed by Guided Therapeutics
are derived from our biophotonic
technology platform. We use light to scan tissue and
detect chemical and structural changes at the cellular level.
Unlike most conventional cancer diagnostics, our technology is
designed to provide a result immediately after the scan and with
no painful tissue sample to be sent to the laboratory.
Our first product is for cervical
precancer detection and is the LuViva®
Advanced Cervical Scan.
Our second product, which is under
development with
Konica Minolta Opto of Japan, is
the Esophageal
Dysplasia Detection System, or EDDS. EDDS is a
non-invasive, point of care device that uses biophotonics to
scan the surface of the esophagus known as the “Barrett’s
Esophagus” area.
| CAUTION - Investigational
device. Limited by federal law to investigational use. The availability
of any product in the U.S. developed from these technologies is
dependent on FDA marketing approval. Global market availability is
dependent on additional regulatory approvals. |
|